Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.21.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional paid in capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Balance (in shares) at Dec. 31, 2019   111,798,000      
Balance at Dec. 31, 2019 $ 298,600 $ 746,487 $ 25,394 $ (805) $ (472,476)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   688,000      
Shares issued on exercise of stock options 2,920 $ 4,450 (1,530)    
Exercise of warrants (in shares)   1,000      
Exercise of warrants 2 $ 3 (1)    
Share-based compensation 3,496   3,496    
Net loss and comprehensive loss for the period (25,932)       (25,932)
Balance (in shares) at Mar. 31, 2020   112,487,000      
Balance at Mar. 31, 2020 $ 279,086 $ 750,940 27,359 (805) (498,408)
Balance (in shares) at Dec. 31, 2020 126,725,000 126,725,000      
Balance at Dec. 31, 2020 $ 407,750 $ 944,328 39,383 (805) (575,156)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   877,000      
Shares issued on exercise of stock options 4,999 $ 7,619 (2,620)    
Exercise of warrants (in shares)   519,000      
Exercise of warrants 31 $ 726 (695)    
Share-based compensation 7,821   7,821    
Other comprehensive income 6     6  
Net loss and comprehensive loss for the period $ (50,379)       (50,379)
Balance (in shares) at Mar. 31, 2021 128,121,000 128,121,000      
Balance at Mar. 31, 2021 $ 370,228 $ 952,673 $ 43,889 $ (799) $ (625,535)